Slingshot members are tracking this corporate initiative:
Dermavant Sciences Licenses Portola's (PTLA) Cerdulatinib for Topical Non-Cancer Applications
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Dec 21, 2016 Projected Implementation: Q1, 2017 Relevance Tracked Until: Q1, 2019
Don’t see a project related to the strategic initiative you care about?
Related Keywords License Agreement, Cerdulatinib, Topical, Non-cancer Applications